Table 1 Cohort Demographics and Covariates by Presence of Antihypertensive PIM Refill after Dialysis Initiation in the Sub-Cohort
Total (n = 5981) | Continued (n = 3920) | Discontinued (n = 2061) | p-value | |
|---|---|---|---|---|
Age at first ESRD service | <0.001 | |||
Mean (SD) | 76 (6) | 75 (6) | 76 (7) | |
Female | 3077 (51%) | 2011 (51%) | 1066 (52%) | 0.75 |
Race/Ethnicity | <0.001 | |||
Non-Hispanic white | 3450 (58%) | 2164 (55%) | 1286 (62%) | |
Non-Hispanic black | 1469 (25%) | 1031 (26%) | 438 (21%) | |
Hispanic | 703 (12%) | 488 (12%) | 215 (10%) | |
Other | 354 (6%) | 237 (6%) | 117 (6%) | |
Medicare/Medicaid Dual Eligible status | 1795 (30%) | 1233 (31%) | 562 (27%) | 0.001 |
Comorbidity Index | <0.001 | |||
Mean (SD) | 8.0 (4.1) | 7.6 (4.1) | 8.8 (4.0) | |
Median (IQR) | 8.0 (5.0, 11.0) | 8.0 (4.0, 11.0) | 9.0 (6.0, 12.0) | |
Diabetes | 4560 (76%) | 3001 (77%) | 1559 (75%) | 0.43 |
Medication count | <0.001 | |||
Mean (SD) | 11 (5) | 12 (5) | 9 (5) | |
Median (IQR) | 11 (8, 14) | 12 (9, 15) | 9 (6, 12) | |
Functional limitations | 1038 (17%) | 622 (16%) | 416 (20%) | <0.001 |
Nursing home residence | 577 (10%) | 292 (7%) | 285 (14%) | <0.001 |
Pre-dialysis nephrology carea | 4194 (70%) | 2807 (72%) | 1387 (67%) | 0.005 |
Pre-dialysis hospitalizationsb | <0.001 | |||
Mean (SD) | 1.6 (1.9) | 1.5 (1.9) | 1.7 (1.9) | |
Median (IQR) | 1.0 (0.0, 2.0) | 1.0 (0.0, 2.0) | 1.0 (0.0, 2.0) | |
For-Profit Facility | 5171 (86%) | 3407 (87%) | 1764 (86%) | 0.16 |
Facility Geographic Region | 0.16 | |||
Northeast | 1007 (17%) | 657 (17%) | 350 (17%) | |
South | 2442 (41%) | 1594 (41%) | 848 (41%) | |
Midwest | 1341 (22%) | 870 (22%) | 471 (23%) | |
West | 1045 (17%) | 713 (18%) | 332 (16%) | |
Unknown | 146 (2%) | 86 (2%) | 60 (3%) | |
ESRD Cause | 0.04 | |||
Diabetes | 2928 (49%) | 1949 (50%) | 749 (47%) | |
Hypertension | 2305 (38%) | 1507 (38%) | 798 (39%) | |
Glomerulonephritis | 246 (4%) | 165 (4%) | 81 (4%) | |
Other | 502 (8%) | 299 (8%) | 203 (10%) |